EcoDrugPlus

Protein Kinase C Zeta

Ensembl ID : ENSCDRG00005011558
Gene Symbol: PRKCZ
1 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSCDRG00005013080
Gene Symbol: PRKD1
1 Cross references
214 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSCDRG00005017670
Gene Symbol: PRKD3
3 Cross references
274 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSCDRG00005015856
Gene Symbol: PRKACA
3 Cross references
288 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSCDRG00005007007
Gene Symbol: PRKACB
3 Cross references
304 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSCDRG00005009363
Gene Symbol: PRKDC
1 Cross references
187 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSCDRG00005017194
Gene Symbol: PPP3CA
1 Cross references
232 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSCDRG00005009649
Gene Symbol: PTK2
1 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSCDRG00005019294
Gene Symbol: PTK2B
3 Cross references
213 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSCDRG00005019660
Gene Symbol: PTPN11
1 Cross references
253 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSCDRG00005018779
Gene Symbol: PTPRB
1 Cross references
268 Possible Orthologues:

Purine Nucleoside Phosphorylase

Ensembl ID : ENSCDRG00005001806
Gene Symbol: PNP
1 Cross references
123 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).